Abstract:In Europe, genetically modified organisms (GMOs) are subject to an authorization process including a mandatory risk assessment. According to the respective guidance by the European Food Safety Authority (EFSA), one of the pillars of this GMO risk assessment is a comparative analysis of the compositional and agronomic characteristics. This targeted approach has been criticized for its limitations, as it only considers pre-determined compounds, being insufficient to assess a comprehensive range of relevant compounds, including toxins and anti-nutrients, on a case-specific basis. Strategies based on advanced untargeted omics technologies have been proposed as a potential broader approach to be implemented into the initial step of the risk assessment framework. Here, we provide an example of a step-by-step omics analysis based on systems biology approach to fit into the context of European GMO regulation. We have performed field trial experiments with genetically modified (GM) IntactaTM Roundup ReadyTM 2 Pro soybean containing both cry1Ac and cp4epsps transgenic inserts and analyzed its proteomic profile against the non-GM counterpart and reference varieties. Based on EFSA's comparative endpoint-by-endpoint approach, the proteomics analysis revealed six proteins from the GMO outside the 99% tolerance intervals of reference varieties (RVs) in the equivalence test. Interestingly, from the near-isogenic (non-GM) comparator we found as many as ten proteins to be outside of the said RVs' equivalence limits. According to EFSA's statistical guidelines, differences found in metabolite abundance between a GMO and its non-GM comparator would not be considered biologically relevant as all compounds of concern remained within the equivalence limits of commercial RVs. By assessing the proteomic and metabolomic data through our proposed systems biology approach, we found 70 proteins, and the metabolite xylobiose as differentially expressed between the GMO and its non-GM comparator. Biological relevance of such results was revealed through a functional biological network analysis, where we found alterations in several metabolic pathways related to protein synthesis and protein processing. Moreover, the allergenicity analysis identified 43 proteins with allergenic potential being differentially expressed in the GM soybean variety. Our results demonstrate that implementation of advanced untargeted omics technologies in the risk assessment of GMOs will enable early and holistic assessment of possible adverse effects. The proposed approach can provide a better understanding of the specific unintended effects of the genetic modification on the plant's metabolism, the involved biological networks, and their interactions, and allows to formulate and investigate dedicated risk hypotheses in the first place. We draw conclusions on a detailed comparison with the comparative assessment according to EFSA and provide scientific arguments and examples on how the current comparative approach is not fit for purpose.

Formation of biogenic amines in a typical semihard Italian cheese.

Assessment of endogenous allergenicity of genetically modified plants exemplified by soybean - Where do we stand?

Assessment of the effect on soil microbial communities of genetically modified soybean and a hybrid from crossing with wild soybean

Allergenicity Assessment of Transgenic Wheat Lines In Silico

Integration of omics analyses into GMO risk assessment in Europe: a case study from soybean field trials

Light Microscopic Study On Schistosoma Mansoni Induced Hepatic And Splenic Lesions Following Praziquantel Treatment

Will genetically modified foods be allergenic?

Food Safety Assessment of Commercial Genetically Modified Soybeans in Rats

Measurement of lipid transfer proteins in genetically engineered maize using liquid chromatography with tandem mass spectrometry (LC-MS/MS).

Assessment of genetically modified soybean GMB151 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2018‐153)

Influence of Genetically Modified Soybean Expressing Epidermal Growth Factor on Arthropod Biodiversity

Effects of Sulfur-rich Amino Acids Transgenic Soybeans on Soil Organic Elements and Microbial Community Diversity

Resistance of Transgenic Maize Cultivars to Mycotoxin Production—Systematic Review and Meta-Analysis

Natural variation explains most transcriptomic changes among maize plants of MON810 and comparable non-GM varieties subjected to two N-fertilization farming practices

Immunoassays and Mass Spectrometry for Determination of Protein Concentrations in Genetically Modified Crops

Development of Multiplex PCR Coupled DNA Chip Technology for Assessment of Endogenous and Exogenous Allergens in GM Soybean

Normal Expression of Insect-Resistant Transgene in Progeny of Common Wild Rice Crossed with Genetically Modified Rice: Its Implication in Ecological Biosafety Assessment

Comparative proteomics of Bt-transgenic and non-transgenic cotton leaves

Glyphosate resistance and no fitness cost in backcross offspring of wild soybean and transgenic soybean with epsps gene

[The impact of components of conventional and genetically modified soybeans on parameters of the immune and reproductive systems in female rats]

Standardization of Allergenicity Assessment of Transgenic Products